All Pharma News
Memo Therapeutics AG Strengthens Management Team

Memo Therapeutics AG Strengthens Management Team
GLOBENEWSWIRE
05 Feb 2024
Share Share
Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer

Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer
BUSINESSWIRE
16 Nov 2023
Share Share
Memo Therapeutics AG Raises CHF 25 Million Series C Financing

Memo Therapeutics AG Raises CHF 25 Million Series C Financing
BUSINESSWIRE
02 Nov 2023
Share Share
Memo enrols first patient in trial of renal infection therapy

Memo enrols first patient in trial of renal infection therapy
CLINICAL TRIALS ARENA
23 Jun 2023
Share Share
Memo Therapeutics AG Starts U.S. Pivotal Phase II/III Clinical Trial with AntiBK

Memo Therapeutics AG Starts U.S. Pivotal Phase II/III Clinical Trial with AntiBK
BUSINESSWIRE
22 Jun 2023
Share Share
Memo Announces PI Data with AntiBKV for Treatment of BKV Infection

Memo Announces PI Data with AntiBKV for Treatment of BKV Infection
BUSINESSWIRE
24 Jan 2023
Share Share
Ono Enters a Drug Discovery Collaboration Agreement with Memo Therapeutics

Ono Enters a Drug Discovery Collaboration Agreement with Memo Therapeutics
PRESS RELEASE
01 Nov 2022
Share Share
Memo Therapeutics initiates pioneering BK virus therapy trial

Memo Therapeutics initiates pioneering BK virus therapy trial
John Pinching PHARMATIMES
31 May 2022
Share Share
Memo Tx Initiates Phase 1 Clinical Study of MTX-005 Against BK Virus Infection

Memo Tx Initiates Phase 1 Clinical Study of MTX-005 Against BK Virus Infection
BUSINESSWIRE
31 May 2022
Share Share
Memo Tx Closes Series B Financing at CHF37M Following CHF23M Extension

Memo Tx Closes Series B Financing at CHF37M Following CHF23M Extension
BUSINESSWIRE
16 Feb 2022
Share Share